More Business Wire
View Older Stories View Newer Stories-
Compliance Scorecard Recognized in Channel Insider’s Inaugural Channel VIP List for Driving MSP Growth and Innovation
-
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
-
IonQ to Highlight Recent Quantum Innovations in Live Webinar, "IonQ's Full-Stack Quantum Innovation"
-
Churchill Asset Management Named 2024 Lender Firm of the Year by The M&A Advisor
-
Blue Lake and CyanVac Report Positive Phase 2a Data for Intranasal COVID-19 Vaccine Candidate
-
Nutcracker Therapeutics Presents Precision Biomanufacturing and CRDMO Solutions at the 2024 Personalized Cancer Vaccine Summit
-
Lazard Appoints Dan Schulman as Lead Independent Director and Peter R. Orszag as Chairman of the Board
-
Expect to See a Spike in In-Store Holiday Shopping This Year, as New Study Shows 53% Increase in Plans to Shop Brick-and-Mortar
-
enGene to Participate in Upcoming Investor Conferences
-
U.S.-Based Remote Robotic-Assisted Surgery Demonstration Successfully Completed Through Collaborations with Virtual Incision, Sovato, City of Hope, and the University of Illinois Chicago
-
Franklin Templeton Fund Adviser, LLC Announces Distributions for the Months of December 2024, January and February 2025
-
Kerrigan Advisors Represents Buckalew Chevrolet in Sale of Houston, Texas Dealership to Keating Auto Group
-
Perfect Corp. and Holidermie Partner to Transform In-Store Skincare with Cutting-Edge AI at Iconic Parisian Destinations
-
Wolfspeed Appoints Melissa Garrett as Senior Vice President and General Counsel
-
HSBC Asset Management Appoints Pete Scott to Lead Venture Debt Offering
-
S1:E2 Launches to Help Businesses Navigate Their Next Phase of Growth
-
Best’s Market Segment Report: US Personal Auto Results Show Significant Improvement; Drive Market Segment Outlook to Stable
-
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
-
SpineThera Celebrates Milestone Achievement with 7th Patent Issued by the US Patent and Trademark Office
-
Office Properties Income Trust Announces Entry into Private Exchange Agreement with Certain Noteholders to Address 2025 Debt Maturities
-
HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500
-
Altius Renewable Royalties Corp. Provides Update on Final Court Order to Approve the Plan of Arrangement with Northampton
-
Arlington Capital Partners Acquires TEAM Technologies
-
Logistic Properties of the Americas Announces Board Approval of Share Repurchase Program
-
Blackstone Mortgage Trust Announces Offering of Senior Secured Notes
-
Arizona Utilities Plan to Join Markets+ to Strengthen Grid Reliability and Resilience
-
Capitolis Announces New Strategic Investments from Citi, Morgan Stanley, State Street and UBS
-
Latino Donor Collaborative (LDC) Launches LDC Latina Initiative, Honoring Billion-Dollar Business Founders Patty Arvielo and Linda Alvarado for Their Pioneering Contributions to the U.S. Economy
-
SolarWinds to Demonstrate How Observability Simplifies Cloud Migration at AWS re:Invent 2024
-
Sagewind Capital Announces Majority Investment in Aechelon Technology
-
VUZE Medical Showcases Concurrent Multi-Tool 3D Guidance in Spine Surgery, With No Navigational Hardware and Using Standard Pre-Op CT
-
In Spain, Veolia Displays Strong Ambitions to Support Ecological Transformation by Putting Expertise and Innovation at the Service of Territories
-
SkyWater Technology Enhances Financial Flexibility with Amended Loan and Security Agreement
-
POSaBIT to Host Third Quarter 2024 Earnings Conference Call
-
NHOA : Implementation of the Compulsory Buyout of the Company's Shares
-
Elida Beauty Conditions its Supply Chain for Success with Kinaxis
-
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
-
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine Demonstrating Early Detection of Patient Deterioration with FDA-cleared BioButton® Continuous Monitoring Wearable Device
-
Mobix Labs Announces Strategic Acquisition of Spacecraft Components
-
Mubadala Capital to Take CI Financial Private via Premium, All-Cash Offer
-
TRUQAP® (capivasertib) combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful improvement in radiographic progress
-
Shorla Oncology Announces FDA Approval of IMKELDI (imatinib) Oral Solution, an Oral Liquid for the Treatment of Certain Forms of Leukemia and Other Cancers
-
Rocket Lab Signs $23.9M CHIPS Incentives Award to Boost Semiconductor Manufacturing
-
Corsair Gaming to Present at Barclays 22nd Annual Global Technology Conference
-
D-Wave Names Sharon Holt to Board of Directors
-
STAAR Surgical to Participate in BTIG Ophthalmology Day
-
Macy’s, Inc. Reports Preliminary Third Quarter 2024 Results
-
AECOM joint venture to provide engineering services for Metro Vancouver’s Iona Island Wastewater Treatment Plant upgrade
-
Berkshire Hathaway Inc. News Release
-
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
